All lobbying filings

CROSSROADS STRATEGIES, LLC

CROSSROADS STRATEGIES, LLC filed a Q3 report for ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) on October 18, 2025, reporting $50,000 in lobbying income.

Lobbying for ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · medical technology association

All filings by CROSSROADS STRATEGIES, LLC · Everything ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 18, 2025

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 6

Budget/Appropriations

Discussions related to the FY2025 budget reconciliation process and H.R.1, One Big Beautiful Bill Act (P.L.119-21), medical device related provisions.

Defense

Policies impacting third party repair of medtech.

Health Issues

General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including Issues related to FDA regulation of medical devices. Issues related to medical device sterilization. Policy issues related to the regulation of artificial intelligence for medical technology. Policies that could impact supply chain for medical technology. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

Medicare/Medicaid

General education to advance policies that support innovation in the medical device industry. Issues related to the coverage and reimbursement of medical devices and technology, including AI. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

Taxation/Internal Revenue Code

Issues related to R&D tax credit; Issues related to tax reform; H.R.1, One Big Beautiful Bill Act (P.L.119-21).

Trade (domestic/foreign)

Policies impacting the supply chain and manufacturing of medical devices and technology including tariffs.

Bills named in this filing 2

H.R. 1
One Big Beautiful Bill Act
H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.